REQUEST A DEMO
Total
USD $0.00
Search more companies

Starpharma S. DE R.L. DE C.V. (Mexico)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Starpharma S. DE R.L. DE C.V. Profile Updated: November 06, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Starpharma S. DE R.L. DE C.V. is an enterprise in Mexico, with the main office in Zapopan. The enterprise currently operates in the Pharmaceutical Preparation Manufacturing sector. It was established on August 08, 2014. 15 (2025) employees currently work for Starpharma S. DE R.L. DE C.V.. From the latest financial highlights, Starpharma S. DE R.L. DE C.V. reported a net sales revenue increase of 42.36% in 2024. During that time, Starpharma S. DE R.L. DE C.V.’s total assets grew by 55.23%. The net profit margin of Starpharma S. DE R.L. DE C.V. increased by 0.67% in 2024.

Headquarters
Carretera A Nogales 4935, Col. San Juan De Ocotan
Zapopan; Jalisco; Postal Code: 45019

Contact Details: Purchase the Starpharma S. DE R.L. DE C.V. report to view the information.

Website: http://www.starpharma.com.mx

Basic Information
Total Employees:
Purchase the Starpharma S. DE R.L. DE C.V. report to view the information.
Financial Auditors:
Purchase the Starpharma S. DE R.L. DE C.V. report to view the information.
Incorporation Date:
August 08, 2014
Key Executives
Purchase this report to view the information.
Chief Financial Officer
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Starpharma S. DE R.L. DE C.V. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MXN. Absolute financial data is included in the purchased report.
Net sales revenue
42.36%
Total operating revenue
42.36%
Operating profit (EBIT)
1361.93%
Net Profit (Loss) for the Period
85.21%
Total assets
55.23%
Total equity
7.92%
Operating Profit Margin (ROS)
7.99%
Net Profit Margin
0.67%
Return on Equity (ROE)
6.66%
Debt to Equity Ratio
46.17%
Quick Ratio
-0.2%
Cash Ratio
0.08%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?